Stay updated on STORM Clinical Trial - Selinexor in Refractory Myeloma
Sign up to get notified when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.

Latest updates to the STORM Clinical Trial - Selinexor in Refractory Myeloma page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new Revision: v3.7.0 entry was added to the study record history, updating the version history. The previous Revision: v3.6.6 entry was removed.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page's revision history shows a new entry: Revision: v3.6.6. The previous revision, v3.6.5, was removed, indicating a minor site update to the study record history.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry, Revision: v3.6.5, was added to the history, and the previous entry Revision: v3.6.4 was removed from the list.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision entry v3.6.4 was added to the record history, replacing the prior revision v3.6.3. This reflects a minor update to the history tracking for the study record.SummaryDifference0.1%

- Check100 days agoChange DetectedThe Record History page now shows a new version label, Revision: v3.6.3, replacing the previous Revision: v3.6.2, indicating a software update to the ClinicalTrials.gov interface.SummaryDifference0.1%

Stay in the know with updates to STORM Clinical Trial - Selinexor in Refractory Myeloma
Enter your email address, and we'll notify you when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.